Kristen Coppock, MA, Editor

An individual treated for HIV is believed to be in long-term remission, according to experts in the United Kingdom. 'The London Patient’ is only the second documented case of sustained remission for HIV infection.

FDA Commissioner Scott Gottlieb, MD, cited that he was “missing” his family as the reason for his impending departure.

Expert witnesses all testified that there is no evidence to support the belief by some parents that vaccines cause autism.

Novo Nordisk is seeking approval for fast-acting insulin aspart (Fiasp) as a new mealtime insulin for children and adolescents with type 1 diabetes.

According to the agency, these drugs are potentially dangerous to consumers in the United States.

IBSA Pharma’s levothyroxine sodium (Tirosint-SOL) oral solution is now available in the United States market for the treatment of hypothyroidism and pituitary thyrotropin suppression.

These products, from Mylan and Dr. Reddy’s Laboratories, are generic equivalents of Indivior PLC’s Suboxone sublingual film.1,2

The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.

The FDA announced approval of Wixela Inhub on January 30, 2019.

The generic product (Wixela Inhub, Mylan) will be offered in 3 strengths at wholesale acquisition costs that are 70% less than the brand equivalent Advair Diskus, according to Mylan.

The disproportionate impact on the US African-American population is highlighted each year on February 7, National Black HIV/AIDS Awareness Day.

At least 79 individual cases of measles in the United States have been reported since the start of 2019.

The FDA is warning patients and doctors that certain test strips used to monitor levels of the blood thinner warfarin may provide inaccurate results and should not be relied upon to adjust the drug dosage.

Recognizing the ongoing opioid crisis and the need to deter theft of drugs, at least 2 medical technology companies—BD and Invistics—have come up with promising digital solutions that track how medications are being dispensed.

Rite Aid pharmacies are providing measles-mumps-rubella (MMR) vaccinations in 2 states that are seeing an increase in reported measles cases.

Conducted by the FDA, an analysis follows a series of recalls for some generic versions of the angiotensin II receptor blocker (ARB) medicines containing nitrosamine impurities that do not meet the agency’s safety standards.

Two lawsuits filed against Walgreens have been settled with the national drug store chain agreeing to pay a total of more than $260 million.

This interoperable standard created to exchange information across the health care spectrum is gaining traction across the country.

Tomorrow, pharmacists will be in the spotlight. It is also an opportunity for them to express pride in their work and share aspects of the job that keep them motivated.

An FDA-approved mobile application for adults with opioid use disorder (OUD) is now available by prescription. Pear Therapeutics’ reSET-O app aims to increase retention for adults who are in outpatient treatment programs.

Swisslog Healthcare's Relay, which will deliver medications and supplies, has the potential to assist staff members with daily tasks and deter drug diversion.

Although there are some advantages and disadvantages to both routes of antibiotic administration, several factors must be considered when determining the best antibiotic delivery method for the patient, including cost, effort of administration, and safety risks.

The specialty drug market saw a 16% growth rate in 2018.

Mobile medical application designed to help increase patient retention for adults with opioid use disorder who are in outpatient treatment programs.

The application is designed to help increase patient retention for adults in outpatient treatment programs.

Health system and hospital pharmacies could see more opportunities for revenue recovery for health system and hospital pharmacies in 2019, as well as increased transparency and access to care for patients.

In a 2-part study, a research team with Desert Regional Medical Center in Corona, CA is analyzing the need for pharmacist intervention for patients with HIV.

The annual forecast predicts developments in different areas that are likely to challenge pharmacy practice leaders in hospitals and health systems in the future.

In a Tuesday session at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Anaheim, CA, some predictions were shared from the ASHP Foundation’s Pharmacy Forecast.

The American Society of Health-System Pharmacists (ASHP) recognized its Donald Francke Medal recipient and other award winners at the 2018 ASHP Midyear Clinical Meeting in Anaheim, CA.